NOVEL ACID SECRETION INHIBITOR AND USE THEREOF
The present invention provides a novel compound represented by Chemical Formula 2, or a pharmaceutically acceptable salt thereof. The novel compound according to the present invention exhibits an excellent acid secretion inhibitory effect.
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
25.10.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides a novel compound represented by Chemical Formula 2, or a pharmaceutically acceptable salt thereof. The novel compound according to the present invention exhibits an excellent acid secretion inhibitory effect. |
---|---|
AbstractList | The present invention provides a novel compound represented by Chemical Formula 2, or a pharmaceutically acceptable salt thereof. The novel compound according to the present invention exhibits an excellent acid secretion inhibitory effect. |
Author | PARK, Joon Tae JE, In Gyu LEE, Jung Woo CHANG, Min Whan LEE, Joo Yun PARK, Jung Eun YOON, Hong Chul IM, A Rang JEON, Woo Jin KANG, Su Yeon HONG, Chang Hee HONG, Da Hae YOO, Yeong Ran KIM, Jung Ho AN, Kyung Mi SHIN, Jae Eui HEO, Jae Ho SOHN, Te Ik SONG, Yoon Sung |
Author_xml | – fullname: KIM, Jung Ho – fullname: JE, In Gyu – fullname: LEE, Jung Woo – fullname: IM, A Rang – fullname: JEON, Woo Jin – fullname: SOHN, Te Ik – fullname: HONG, Chang Hee – fullname: YOO, Yeong Ran – fullname: HEO, Jae Ho – fullname: HONG, Da Hae – fullname: SHIN, Jae Eui – fullname: CHANG, Min Whan – fullname: PARK, Jung Eun – fullname: SONG, Yoon Sung – fullname: PARK, Joon Tae – fullname: KANG, Su Yeon – fullname: AN, Kyung Mi – fullname: LEE, Joo Yun – fullname: YOON, Hong Chul |
BookMark | eNrjYmDJy89L5WTQ8_MPc_VRcHT2dFEIdnUOcg3x9PdT8PTz8HTyDPEPUnD0c1EIDXZVCPFwDXL1d-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuASaGJhYGpgaOJsZEKAEAdp8m4w |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | NOUVEL INHIBITEUR DE SÉCRÉTION D'ACIDE ET SON UTILISATION NEUARTIGER SÄURESEKRETIONSHEMMER UND VERWENDUNG DAVON |
ExternalDocumentID | EP4148050A4 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP4148050A43 |
IEDL.DBID | EVB |
IngestDate | Fri Oct 18 05:56:58 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP4148050A43 |
Notes | Application Number: EP20210826347 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231025&DB=EPODOC&CC=EP&NR=4148050A4 |
ParticipantIDs | epo_espacenet_EP4148050A4 |
PublicationCentury | 2000 |
PublicationDate | 20231025 |
PublicationDateYYYYMMDD | 2023-10-25 |
PublicationDate_xml | – month: 10 year: 2023 text: 20231025 day: 25 |
PublicationDecade | 2020 |
PublicationYear | 2023 |
RelatedCompanies | Ildong Pharmaceutical Co., Ltd |
RelatedCompanies_xml | – name: Ildong Pharmaceutical Co., Ltd |
Score | 3.4950092 |
Snippet | The present invention provides a novel compound represented by Chemical Formula 2, or a pharmaceutically acceptable salt thereof. The novel compound according... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | NOVEL ACID SECRETION INHIBITOR AND USE THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231025&DB=EPODOC&locale=&CC=EP&NR=4148050A4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvVNUSN-pQ9mb9OltBt7WAx0XTYjGxmD8EZW2BJekMiM_77XBdAXfbu0ybW95O5-d-1dAR4Vp7nToY6Zz_PCZHbpmt2S22ZJFzZXvIM-Sxc4D2I7HLPXKZ82YLmrhan7hH7VzRFRo-ao71Vtr9c_SSy_flu5eVZLHHp_CTLPN7bRsQYrlBt-35PDxE-EIQRSRpx6DGG_xa0eO4BDRNGOVgY56euilPVvjxKcwdEQma2qc2gUqxaciN3Hay04Hmzvu5Hcqt7mAp7iZCLfSE9EPhlJkUqdWyJRHEb9KEtS0ot9Mh5JkoUylUlwCSSQmQhNXHi2P-RMDvdb7FxBE2P_4hoILdnCVjYtuasYdayu4o5LKWI2K3cdztrQ_pPNzT9zt3CqpaWNMOV30Kw-Pot79K6Veqjl8g13_3id |
link.rule.ids | 230,309,783,888,25576,76882 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUSN-9sHsbbp07cYeFgNdl01hI2MQ3sgKW8ILEpnx37ddBvqib5c2uX4kd_e7a-8O4FFQnNkmtvVskeU6sQpH7xbU0gu8tKigprRZKsF5GFnBhLzO6KwBq10uTFUn9KsqjiglaiHlvaz09eYniOVVfyu3z2Ilh95f_NT1tNo7VmAFU83ru3wUezHTGJOUFiUukbDfoEaPHMChRNhd1eyAT_sqKWXz26L4p3A0kszW5Rk08nUbWmzXeK0Nx8P6vVuStehtz-Epiqd8gHos9NCYs4Sr2BIKoyDsh2mcoF7kocmYozTgCY_9C0A-T1mgy4Xn-0PO-Wi_RfMSmtL3z68A4YIsLWHhgjqCYNvoCmo7GEvMZmSOTUkHOn-yuf5n7gFaQToczAdh9HYDJ-rmlELG9Baa5cdnfictbSnuqzv6Bkene40 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+ACID+SECRETION+INHIBITOR+AND+USE+THEREOF&rft.inventor=KIM%2C+Jung+Ho&rft.inventor=JE%2C+In+Gyu&rft.inventor=LEE%2C+Jung+Woo&rft.inventor=IM%2C+A+Rang&rft.inventor=JEON%2C+Woo+Jin&rft.inventor=SOHN%2C+Te+Ik&rft.inventor=HONG%2C+Chang+Hee&rft.inventor=YOO%2C+Yeong+Ran&rft.inventor=HEO%2C+Jae+Ho&rft.inventor=HONG%2C+Da+Hae&rft.inventor=SHIN%2C+Jae+Eui&rft.inventor=CHANG%2C+Min+Whan&rft.inventor=PARK%2C+Jung+Eun&rft.inventor=SONG%2C+Yoon+Sung&rft.inventor=PARK%2C+Joon+Tae&rft.inventor=KANG%2C+Su+Yeon&rft.inventor=AN%2C+Kyung+Mi&rft.inventor=LEE%2C+Joo+Yun&rft.inventor=YOON%2C+Hong+Chul&rft.date=2023-10-25&rft.externalDBID=A4&rft.externalDocID=EP4148050A4 |